It may not look like it on the basis of the last few quarters, but Agilent (NYSE:A)
is getting better. Weakness in multiple test and measurement
end-markets and lower government spending are generating stiff
headwinds, but the company continues to roll out strong new products,
and the long-term potential in chemical analysis and diagnostics remains
impressive. Even though Agilent is near a 52-week high, I believe
shareholders could still do reasonably well with this stock,
particularly if their investment horizon is more than just a quarter or
two.
Continue here:
http://www.investopedia.com/stock-analysis/081513/agilent-grinding-through-challenging-market-conditions-dhr-tmo-jdsu.aspx
No comments:
Post a Comment